Erick J. Morris

4.7k citations

25 papers · 2.8k indexed · h-index 22

Impact in

Developmental Neuroscience top 5%
Oncology top 2%
- Cancer-related Molecular Pathways

Papers in

Oncology 16
- Cancer-related Molecular Pathways 14
Physiology 2
- Adenosine and Purinergic Signaling 2

Co-authors: Herbert M. Geller Nicholas J. Dyson David S. Park Lloyd A. Greene Michael L. Shelanski Ruth S. Slack Jaya Padmanabhan William J. Nicklas
Journals: Journal of Neuroscience (5 papers)The Journal of Cell Biology (2 papers)PLoS Genetics (2 papers)Journal of Biological Chemistry (2 papers)Journal of Neurochemistry (2 papers)
Partner nations: United States Canada Switzerland

In The Last Decade

Erick J. Morris

24 papers receiving 2.7k citations

Peers

Countries citing papers authored by Erick J. Morris

Since Specialization

Citations

This map shows the geographic impact of Erick J. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erick J. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erick J. Morris more than expected).

Fields of papers citing papers by Erick J. Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erick J. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erick J. Morris. The network helps show where Erick J. Morris may publish in the future.

Co-authors

The 25 scholars most cited alongside Erick J. Morris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erick J. Morris Line = papers co-authored together Erick J. Morris links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non–Small Cell Lung Cancer Clinical Cancer Research ·Alberto Chiappori, Ben Creelan, Tawee Tanvetyanon, Jhanelle E. Gray, Eric B. Haura, Ram Thapa, Margaret L. Barlow, Zhihua Chen, Dung Tsa Chen, Amer A. Beg, Theresa A. Boyle, Julio Castro, Liza Morgan, Erick J. Morris, Mehreteab Aregay, Felipe K. Hurtado, Luigi Manenti, Scott Antonia	2022	50
2	Phase I/II study of the A2AR antagonist NIR178 (PBF-509), an oral immunotherapy, in patients (pts) with advanced NSCLC. Journal of Clinical Oncology ·Alberto Chiappori, Charles C. Williams, Ben Creelan, Tawee Tanvetyanon, Jhanelle E. Gray, Eric B. Haura, Ram Thapa, Dung‐Tsa Chen, Amer A. Beg, Theresa A. Boyle, Jennifer Bendiske, Erick J. Morris, Aiyang Tao, Felipe K. Hurtado, Luigi Manenti, Julio Castro, Scott Antonia	2018	37
3	Dissecting Therapeutic Resistance to ERK Inhibition Molecular Cancer Therapeutics ·Sharda Jha, Erick J. Morris, Alan Hruza, My Sam Mansueto, Gottfried K. Schroeder, Jaren Arbanas, Daniel R. McMasters, Clifford R. Restaino, Priya Dayananth, Stuart Black, Nathaniel L. Elsen, Anthony Mannarino, Alan Cooper, Stephen E. Fawell, Leigh Zawel, Lata Jayaraman, Ahmed A. Samatar	2016	39
4	High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells Cancer Research ·Thomas Horn, Stéphane Ferretti, Nicolas Ebel, Angela Tam, Samuel B. Ho, Fred Harbinski, Ali Farsidjani, Matthew Zubrowski, William R. Sellers, Robert Schlegel, Dale Porter, Erick J. Morris, Jens Wuerthner, Sébastien Jeay, Joel Greshock, Ensar Halilovic, Levi A. Garraway, Giordano Caponigro, Joseph Lehár	2016	24
5	E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8 Nature ·Erick J. Morris, Jun‐Yuan Ji, Fajun Yang, Luisa Di Stefano, Anabel Herr, Nam Sung Moon, Eun Jeong Kwon, Kevin M. Haigis, Anders M. Näär, Nicholas J. Dyson	2008	236
6	E2F and p53 Induce Apoptosis Independently during Drosophila Development but Intersect in the Context of DNA Damage PLoS Genetics ·Nam-Sung Moon, Luisa Di Stefano, Erick J. Morris, Reena G. Patel, Kristin White, Nicholas J. Dyson	2008	55
7	Functional Identification of Api5 as a Suppressor of E2F-Dependent Apoptosis In Vivo PLoS Genetics ·Erick J. Morris, William A. Michaud, Jun‐Yuan Ji, Nam-Sung Moon, James W. Rocco, Nicholas J. Dyson	2006	97
8	The Chk1/Cdc25A Pathway as Activators of the Cell Cycle in Neuronal Death Induced by Camptothecin Journal of Neuroscience ·Yi Zhang, Dianbo Qu, Erick J. Morris, Michael J. O’Hare, Steven Callaghan, Ruth S. Slack, Herbert M. Geller, David S. Park	2006	46
9	Drosophila E2F1 Has Context-Specific Pro- and Antiapoptotic Properties during Development Developmental Cell ·Nam-Sung Moon, Maxim V. Frolov, Eun-Jeong Kwon, Luisa Di Stefano, Dessislava K. Dimova, Erick J. Morris, Barbie Taylor‐Harding, Kristin White, Nicholas J. Dyson	2005	65
10	G1 cyclin-dependent kinases are insufficient to reverse dE2F2-mediated repression Genes & Development ·Maxim V. Frolov, Olivier Nolan-Stevaux, Nam-Sung Moon, Dessislava K. Dimova, Eun-Jeong Kwon, Erick J. Morris, Nicholas J. Dyson	2003	25
11	Retinoblastoma protein partners Advances in cancer research ·Erick J. Morris, Nicholas J. Dyson	2001	279
12	Oxidative stress mediates neuronal DNA damage and apoptosis in response to cytosine arabinoside Journal of Neurochemistry ·Herbert M. Geller, Ke‐Yi Cheng, Noriko K. Goldsmith, Alejandro A. Romero, Ai‐Ling Zhang, Erick J. Morris, Lindsey Grandison	2001	96
13	Cyclin-Dependent Kinases and P53 Pathways Are Activated Independently and Mediate Bax Activation in Neurons after DNA Damage Journal of Neuroscience ·Erick J. Morris, Elizabeth Keramaris, Hardy J. Rideout, Ruth S. Slack, Nicholas J. Dyson, Leonidas Stefanis, David S. Park	2001	94
14	E2F1 Mediates Death of B-amyloid-treated Cortical Neurons in a Manner Independent of p53 and Dependent on Bax and Caspase 3 Journal of Biological Chemistry ·Andrew Giovanni, Elizabeth Keramaris, Erick J. Morris, Sheng‐Tao Hou, Michael J. O’Hare, Nick Dyson, George S. Robertson, Ruth S. Slack, David S. Park	2000	182
15	Induction and Modulation of Cerebellar Granule Neuron Death by E2F-1 Journal of Biological Chemistry ·Michael J. O’Hare, Sheng‐Tao Hou, Erick J. Morris, Sean P. Cregan, Qin Xu, Ruth S. Slack, David S. Park	2000	127
16	Involvement of Retinoblastoma Family Members and E2F/DP Complexes in the Death of Neurons Evoked by DNA Damage Journal of Neuroscience ·David S. Park, Erick J. Morris, Rod Bremner, Elizabeth Keramaris, Jaya Padmanabhan, Michele Rosenbaum, Michael L. Shelanski, Herbert M. Geller, Lloyd A. Greene	2000	135
17	Optimization of Single-Cell Gel Electrophoresis (SCGE) for Quantitative Analysis of Neuronal DNA Damage BioTechniques ·Erick J. Morris, J.C. Dreixler, Ke-Yi Cheng, P. M. Wilson, Ramon Gin�, Herbert M. Geller	1999	41
18	Multiple Pathways of Neuronal Death Induced by DNA-Damaging Agents, NGF Deprivation, and Oxidative Stress Journal of Neuroscience ·David S. Park, Erick J. Morris, Leonidas Stefanis, Carol M. Troy, Michael L. Shelanski, Herbert M. Geller, Lloyd A. Greene	1998	214
19	Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity. The Journal of Cell Biology ·Erick J. Morris, Herbert M. Geller	1996	261
20	l‐DOPA Cytotoxicity to PC12 Cells in Culture Is via Its Autoxidation Journal of Neurochemistry ·Alie N. Basma, Erick J. Morris, William J. Nicklas, Herbert M. Geller	1995	194

About Erick J. Morris

Erick J. Morris is a scholar working on Oncology, Physiology, Molecular Biology, Cell Biology and Toxicology, having authored 25 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (14 papers), Cell death mechanisms and regulation (10 papers), DNA Repair Mechanisms (5 papers), Cancer therapeutics and mechanisms (3 papers), Microtubule and mitosis dynamics (3 papers), Computational Drug Discovery Methods (2 papers), Melanoma and MAPK Pathways (2 papers) and Adenosine and Purinergic Signaling (2 papers). The work is most often cited by research in Developmental Neuroscience (175 citations), Oncology (1.1k citations), Molecular Biology (2.0k citations), Cellular and Molecular Neuroscience (456 citations) and Cell Biology (384 citations). Erick J. Morris has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Herbert M. Geller, Nicholas J. Dyson, David S. Park, Lloyd A. Greene, Michael L. Shelanski, Ruth S. Slack, Jaya Padmanabhan, William J. Nicklas, Alie N. Basma and Elizabeth Keramaris. Their work appears in journals such as Journal of Neuroscience, The Journal of Cell Biology, PLoS Genetics, Journal of Biological Chemistry and Journal of Neurochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact